Gynecomastia Surgery in India and UAE | Complete Patient Guide

• Male patients aged 18 and above with persistent gynecomastia lasting more than 12 months despite conservative treatment

• Patients with Simon Grade I, IIa, IIb, or Grade III gynecomastia confirmed on physical examination and ultrasound

• Individuals with pseudogynecomastia (predominantly fatty tissue) who wish chest contouring

• Patients in good general health with a BMI ideally below 30 (cases up to BMI 35 evaluated individually by the surgical team)

• Adolescents (16–17) considered on a case-by-case basis only after documented hormonal stabilisation and parental/guardian consent

Required Pre-operative Diagnostics:

• Serum hormonal panel: total testosterone, free testosterone, oestradiol (E2), LH, FSH, prolactin, TSH, and beta-hCG to exclude endocrine pathology or occult testicular tumour

• Liver function tests and renal function panel to assess metabolic contributors

• Breast ultrasound (mandatory) to distinguish glandular from fatty tissue, rule out fibroadenoma, and exclude rare male breast carcinoma

• Mammography or MRI of the chest wall in cases with hard, eccentric, or rapidly progressive masses to exclude malignancy

• ECG and anaesthetic fitness evaluation for patients over 40 or with cardiovascular co-morbidities

• Full blood count, coagulation profile (PT/INR/aPTT), and fasting glucose

Contraindications:

• Active male breast carcinoma or unresolved suspicious mammographic lesion

• Untreated primary endocrine disorder causing secondary gynecomastia (surgery deferred until hormonal cause is managed)

• Severe uncontrolled coagulopathy or active anticoagulation that cannot be bridged

• Active smokers advised to cease smoking at least 4 weeks pre-operatively to reduce wound healing risk

• BMI above 40 — surgical risk reassessed and bariatric management recommended first

• Unrealistic expectations or unaddressed body dysmorphic disorder confirmed on psychological screening

Gynecomastia surgery encompasses a spectrum of techniques selected according to the Simon/Rohrich grade, tissue composition (glandular vs. fatty), degree of skin excess, and patient anatomy. Modern centres in India and the UAE offer all of the following approaches:

Standard Surgical Excision (Open Technique):

The classic approach involves a periareolar incision (along the inferior or complete circumference of the areola) through which hypertrophied glandular breast disc tissue is excised under direct vision. This technique is mandatory for Grade IIb and Grade III gynecomastia where a firm, fibrous glandular component cannot be aspirated by liposuction alone. The incision is concealed at the areolar border, making scars largely imperceptible at 6–12 months post-operatively. In severe Grade III cases with significant ptosis and skin redundancy, skin resculpting with a free nipple graft technique or a concentric mastopexy pattern may be employed.

Liposuction-Assisted Techniques:

For predominantly fatty or mixed subtypes (Rohrich Type II–III), power-assisted liposuction (PAL) or ultrasound-assisted liposuction (UAL/VASER) is the primary modality. VASER (Vibration Amplification of Sound Energy at Resonance) Hi-Def liposuction uses third-generation ultrasonic energy to selectively emulsify adipose tissue while preserving neurovascular structures, enabling high-definition chest sculpting with minimal bruising, reduced post-operative pain, and faster recovery compared to conventional suction-assisted lipectomy (SAL). VASER is now considered the gold standard for fatty-predominant gynecomastia in premium centres.

Combination (Hybrid) Approach:

The most commonly performed procedure in high-volume centres combines VASER or PAL liposuction with periareolar glandular excision. Liposuction first softens the fibrous stroma and removes peripheral fat, after which the residual glandular disc is excised through a small periareolar incision. This minimises incision size while addressing both tissue components comprehensively.

Energy-Based Adjuncts:

• Renuvion (J-Plasma/Helium Plasma): Subdermal skin tightening using cold plasma energy is offered in select advanced centres to address mild-to-moderate skin laxity in Grade IIb cases, potentially avoiding skin excision.

• Laser-Assisted Liposuction (e.g., SmartLipo): Used in selected cases for simultaneous fat removal and collagen stimulation.

Endoscopic Assistance:

In select centres in India and the UAE, endoscopic assistance enables gland excision through incisions as small as 4–5 mm, reducing visible scarring further.

Minimally Invasive Pull-Through Technique:

A specialised approach using a 3–4 mm stab incision at the areolar border through which the glandular tissue is delivered with a clamp under direct endoscopic or ultrasound guidance — suitable for Grade I and early Grade IIa cases with a well-defined glandular disc.

The choice of technique is finalised during the pre-operative consultation, incorporating 3D imaging assessment (Vectra 3D or equivalent) available at leading centres in both India and the UAE to simulate post-operative outcomes and optimise patient alignment.

Pre-Operative Phase (4–6 Weeks Before Surgery):

• GAF Healthcare coordinates a teleconsultation with the chosen plastic surgeon, who reviews uploaded investigations, photographs, and medical history.

• Hormone panel and imaging results are analysed; additional tests ordered if required.

• Surgical plan (technique, anaesthesia type — general anaesthesia vs. tumescent local anaesthesia with sedation) is confirmed in writing.

• Medications to discontinue: aspirin, NSAIDs, vitamin E, herbal supplements, and anticoagulants at least 7–10 days pre-operatively. Tamoxifen, if prescribed, is reviewed.

• Smoking cessation confirmed at least 4 weeks prior.

• GAF Healthcare arranges e-Medical visa (India) or UAE entry documentation, flight, and pre-operative accommodation.

Arrival & Pre-Operative Day (Day 0–1):

• Airport reception by GAF Healthcare concierge; transfer to hospital or partner accommodation.

• In-person surgical consultation and physical examination; anaesthetic fitness review.

• Signed informed consent covering technique, risks, revision policy, and expected outcomes.

• Pre-operative photography and 3D body imaging where available.

• Nil by mouth from midnight before procedure.

Surgery Day (Day 1):

• Procedure performed under general anaesthesia or tumescent local anaesthesia with IV sedation; duration 1–2.5 hours depending on grade and technique.

• VASER/PAL liposuction performed first via 3–4 mm stab incisions in the axillary or inframammary crease.

• Periareolar glandular excision performed as required.

• Closed-suction drains placed if indicated (typically for Grade IIb/III cases).

• Compressive chest vest applied immediately post-operatively.

• Patient transferred to recovery; most patients discharged same day or after one overnight observation.

Post-Operative Days 2–7:

• Drain output monitored and documented; drains removed when output falls below 20–30 mL/24 hours (typically Day 2–4).

• Oral analgesics (paracetamol ± tramadol), prophylactic antibiotics (typically 5 days), and anti-emetics prescribed.

• Light ambulation encouraged from Day 1; showering permitted after drain removal.

• GAF Healthcare nursing liaison visits or telehealth check-in on Days 2, 4, and 7.

• Compression vest worn continuously (24 hours/day) for the first 3–4 weeks.

Week 1–2 (Fit-to-Fly Assessment):

• Suture removal or wound check at Day 7–10.

• Swelling and bruising peak at Day 3–5 and begin resolving.

• International flight cleared by surgeon at Day 10–14 for uncomplicated cases; compression vest worn during travel.

• Light desk work resumed at Day 7–10; avoid driving until off narcotic analgesia.

Weeks 3–6:

• Compression garment continued for 4–6 weeks total.

• Return to light cardiovascular exercise (walking, cycling) from Week 3.

• Avoid chest pressing movements, heavy lifting, or contact sports for 6 weeks.

• Scar management initiated at Week 3: silicone gel sheets and/or topical silicone gel applied to periareolar incisions.

Months 2–6:

• Progressive return to full exercise including weight training from Week 6–8 with surgeon clearance.

• Final aesthetic result assessed at 3–6 months as residual swelling resolves completely.

• Remote follow-up teleconsultation with GAF Healthcare at Month 1, 3, and 6.

• Scar maturation continues for 12–18 months; most periareolar scars fade to barely perceptible lines.